Patton Fund Management’s Edwards Lifesciences EW Stock Holding History

Patton Fund Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,739	Closed	-$219K	–	226
2026 Q1	$219K	Hold	2,739	–	–	0.04%	424
2025 Q4	$234K	Sell	2,739 -157	-5%	-$12.9K	0.03%	199
2025 Q3	$225K	Hold	2,896	–	–	0.04%	355
2025 Q2	$226K	Buy	+2,896	New	+$216K	0.05%	336
2020 Q2	–	Sell	-11,820	Closed	-$743K	–	81
2020 Q1	$743K	Sell	11,820 -37,137	-76%	-$2.68M	0.46%	60
2019 Q4	$3.81M	Buy	48,957 +237	+0.5%	+$18.5K	1.33%	23
2019 Q3	$3.57M	Sell	48,720 -9,408	-16%	-$661K	1.43%	15
2019 Q2	$3.58M	Buy	+58,128	New	+$3.51M	1.42%	14

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Patton Fund Management's EW Position: Q2 2026 in Review

Patton Fund Management sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 2,739 shares — an estimated $219K sold.

Patton Fund Management first reported a position in EW in Q2 2019 and held it in 8 quarters. The position peaked at $3.81M in Q4 2019. 458 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Patton Fund Management reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
Patton Fund Management sold 2,739 Edwards Lifesciences shares in Q2 2026, an estimated $219K.
Patton Fund Management first reported a position in Edwards Lifesciences in Q2 2019 and held it in 8 quarters.
Patton Fund Management's Edwards Lifesciences position peaked at $3.81M in Q4 2019.
458 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.